格隆汇8月4日丨致尚科技(301486.SZ)在互动平台表示，目前，公司在越南有两处生产基地，一处位于 越南北江，面积约7,000平方米，已于2023年底开始投产；另一处位于越南永福，面积约20,000平方米， 于今年开始投产。两处越南生产基地将主要生产单芯光纤跳线、单芯集束光纤跳线、多芯MPO光纤跳 线和光分路器等。公司具备承接各类客户光通信产品订单的能力。 ...

Group 1 - Vanke A's largest shareholder, Shenzhen Metro Group, plans to provide a loan of up to 3 billion yuan to the company for repaying bond principal and interest [1] - The loan term will not exceed 36 months, with an interest rate based on the 1-year Loan Prime Rate (LPR) minus 66 basis points, currently at 2.34% [1] Group 2 - Gongchuang Turf's stock price has increased for five consecutive trading days, with a total rise of 58.00%, significantly deviating from the Shanghai Composite Index [2] - The company generates 88.62% of its revenue from overseas, and is closely monitoring the uncertain U.S. tariff policies [2] - In 2024, the revenue from leisure grass and sports grass is projected to be 2.052 billion yuan and 594 million yuan, accounting for 69.93% and 20.25% of main business revenue, respectively [2] Group 3 - Jinling Sports announced that some venues in the Scottish Premier League used the company's football competition equipment, but the impact on the company's performance is currently minimal [3] Group 4 - Filinger's stock has seen significant increases, but the completion of the control transfer remains uncertain, pending regulatory approval [4] - The company has not disclosed any major changes in its fundamentals [4] Group 5 - Huamai Technology's business is currently focused on communication infrastructure, including optical communication products and wireless communication network construction products [5] Group 6 - Longbai Group plans to repurchase shares worth 500 million to 1 billion yuan for employee stock ownership plans, with a maximum repurchase price of 24.82 yuan per share [6] Group 7 - Stone Technology intends to issue H-shares and list on the Hong Kong Stock Exchange, pending shareholder approval and regulatory approvals [7] Group 8 - ST Tianyu and its actual controller are under investigation by the CSRC for suspected information disclosure violations, but this will not significantly impact the company's operations [8][9] Group 9 - Honghui Fruits' controlling shareholder is planning a share transfer that may lead to a change in control, resulting in a temporary suspension of trading [10] Group 10 - Cambridge Technology's major shareholders plan to reduce their holdings by up to 8.0413 million shares, representing 3.00% of the total shares [11] Group 11 - Jialin Jie announced that its controlling shareholder's associates received administrative penalties unrelated to the company, which will not affect its daily operations [12] Group 12 - GAC Group reported a May automobile sales figure of 117,698 units, a year-on-year decline of 24.80% [13] - Shennong Group sold 232,800 pigs in May, generating revenue of 413 million yuan [14] - Dabeinong sold 727,600 pigs in May, with revenue of 1.248 billion yuan [15] - Tangrenshen's pig sales increased by 47.69% year-on-year in May, with total revenue rising by 44.97% [16] Group 13 - Jiacheng International signed a two-year air transport service contract with a well-known e-commerce platform, ensuring annual revenue of no less than 500 million yuan [18] Group 14 - Zhonggu Logistics' shareholders plan to reduce their holdings by up to 3% of the company's shares [20] - CITIC Guoan intends to reduce its holdings of Hubei Broadcasting shares by up to 11.37 million shares [20]

Group 1 - Lianhua Technology's K-amine product maintains stable gross profit and has not received any increase in customer demand notifications [1] - Yara International's supervisor Peng Zhiyun is under investigation for insider trading, which is unrelated to the company's operations [2] - Sangfor Technologies' application for a new drug, a recombinant human anti-IL-1β monoclonal antibody injection, has been accepted for review by the National Medical Products Administration [3] Group 2 - Maipu Medical plans to acquire 100% equity of Yijie Medical and raise matching funds, with the stock resuming trading [4] - ZaiJing Pharmaceutical signed an exclusive marketing service agreement for a recombinant human thyroid-stimulating hormone injection, with potential revenue of up to RMB 250 million [5] - Haitai Development is planning to purchase controlling interest in Zhixueyun, which may constitute a major asset restructuring [6] Group 3 - Shuyou Pharmaceutical's STSP-0601 injection has been included in the priority review list by the National Medical Products Administration [7] - Yuyin Co. confirmed no undisclosed major matters affecting stock trading amid abnormal price fluctuations [8][9] - Chengdi Xiangjiang's subsidiary won a bid for a RMB 440 million project with China Mobile for data center power system construction [10] Group 4 - Huamai Technology's business focuses on communication infrastructure, with no significant changes in the market environment [11] - Huijin Co. reported normal production and operations, confirming no undisclosed major matters amid stock price fluctuations [12] Group 5 - Wenta Technology's shareholder plans to reduce holdings by up to 3% [15] - Jingfang Technology's investor intends to reduce holdings by no more than 2% [15] - Yanmian Technology's controlling shareholder plans to reduce holdings by up to 2% [15] - Debang Technology's national integrated circuit fund has cumulatively reduced its holdings by 1% [15] - Lanjian Intelligent plans to repurchase shares worth between RMB 10 million and 20 million [15] - Chengdi Xiangjiang's joint venture won a RMB 440 million project [15] - Alter signed a RMB 214 million technology development contract [15] - Zhongyou Engineering's subsidiary received a contract worth approximately RMB 2.122 billion for a gas pipeline project in Iraq [15]

Group 1 - Haitai Development plans to acquire controlling stake in Zhixueyun through cash, which may constitute a major asset restructuring [3] - Shutaishen's product STSP-0601 has been included in the priority review list by the National Medical Products Administration, entering the expedited approval process [4] - Yuyin Co. confirmed no undisclosed significant matters despite stock price fluctuations exceeding 20% over three trading days [5] Group 2 - ST Four Seasons announced the resignation of three vice presidents due to personal reasons [6] - Wanda Film is set to launch a shareholder reward program, offering discounted movie vouchers and exclusive purchase options for shareholders [7] - Huamai Technology reported normal business operations focused on communication infrastructure, with no undisclosed significant information [8] Group 3 - Cuiwei Co. is currently experiencing losses in its main business due to market conditions and operational changes [9] - Dongfang Yuhong has received government subsidies totaling 11.3344 million yuan, accounting for 10.48% of the audited net profit for 2024 [10] Group 4 - Wen's Co. reported a 14.23% year-on-year increase in pig sales revenue for May, with total sales of 3.1554 million pigs generating 5.323 billion yuan [12] - Wentaike plans to reduce its stake by up to 3% through block trades and centralized bidding, amounting to 37.3374 million shares [14] - Debang Technology has reduced its shareholding by 1% through block trades, now holding 16.83% of the company [15] Group 5 - Lanjian Intelligent plans to repurchase shares worth 10 to 20 million yuan at a maximum price of 41.88 yuan per share [17] - Chengdi Xiangjiang's subsidiary has won a bid for a 440 million yuan project with China Mobile for data center power system construction [19]

【导读】致尚科技拟筹划重大资产重组，自4月8日开市起停牌 中国基金报记者 邱德坤 4月7日晚间，致尚科技公告称，公司正在筹划以发行股份及支付现金方式购买深圳市恒扬数据股份有限 公司（以下简称恒扬数据）的控制权，预计构成重大资产重组。 据悉，致尚科技将持续加码光通信产业，该产业被认为是AI时代的算力基础。而在AI智算等技术加速 发展的背景下，恒扬数据将深耕智能计算与高性能数据处理领域。 公告显示，本次交易事项尚处于筹划阶段，致尚科技初步确定的交易对方为恒扬数据的全部股东。 天眼查显示，恒扬数据的主要股东包含深圳市海纳天勤投资有限公司、深圳市中博文投资有限公司、深 圳市法兰克奇投资有限公司等。 来源：天眼查 《合作备忘录》显示，恒扬数据相关股权的最终交易价格，以致尚科技聘请具有证券期货业务资格的评 估机构，通过出具资产评估报告确认的评估值为基础，再由各方协商确定。 公告显示，经初步测算，本次交易预计构成《上市公司重大资产重组管理办法》规定的重大资产重组。 致尚科技计划自4月8日开市起停牌，预计停牌时间不超过10个交易日。截至4月7日收盘，公司股价报 40.04元/股，总市值为51.52亿元。 初步确定交易对方为标 ...